These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Diagnostic and therapeutic approach in cancer of metastatic presentation and unknown origin]. Losa Gaspà F; Germà Lluch JR; Camacho Cuartero L; Niubó Daniel R; Albareda Boleda JM; Sanuy Jiménez B; Martos Rodríguez A Rev Clin Esp; 2002 Nov; 202(11):604-14. PubMed ID: 12392650 [No Abstract] [Full Text] [Related]
24. Clinical guideline SEOM: cancer of unknown primary site. Collado Martín R; García Palomo A; de la Cruz Merino L; Borrega García P; Barón Duarte FJ; Clin Transl Oncol; 2014 Dec; 16(12):1091-7. PubMed ID: 25392080 [TBL] [Abstract][Full Text] [Related]
25. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site]. Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281 [TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and therapy of tumors from an unknown primary site]. Novik AV; Moiseenko VM Vopr Onkol; 2004; 50(3):271-8. PubMed ID: 15318700 [No Abstract] [Full Text] [Related]
27. Diagnosis and management of metastatic neoplasms with unknown primary. Bochtler T; Löffler H; Krämer A Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116 [TBL] [Abstract][Full Text] [Related]
28. Treatment of patients with cancer of an unknown primary site. Hainsworth JD; Greco FA N Engl J Med; 1993 Jul; 329(4):257-63. PubMed ID: 8316270 [No Abstract] [Full Text] [Related]
29. Tailoring therapy to hidden primary tumors. Cancer Discov; 2015 May; 5(5):OF5. PubMed ID: 25788658 [No Abstract] [Full Text] [Related]
30. [Standard of care of carcinomas on cancer of unknown primary site in 2016]. Benderra MA; Ilié M; Hofman P; Massard C Bull Cancer; 2016; 103(7-8):697-705. PubMed ID: 27372228 [TBL] [Abstract][Full Text] [Related]
36. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up. Briasoulis E; Pavlidis N; Felip E; Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742 [No Abstract] [Full Text] [Related]
37. New era: prospects for managing cancer of unknown primary. Li Y; Bai Y; Ji H; Liu Z; Zhang H Cancer Biol Med; 2023 Aug; 20(8):562-7. PubMed ID: 37646233 [No Abstract] [Full Text] [Related]
38. Carcinoma of Unknown Primary Site: The Poster Child for Personalized Medicine? Varadhachary G JAMA Oncol; 2015 Apr; 1(1):19-21. PubMed ID: 26182299 [No Abstract] [Full Text] [Related]
39. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G; Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507 [No Abstract] [Full Text] [Related]
40. Cancer of unknown primary: does the key lie in molecular diagnostics? Green AC Cytopathology; 2015 Feb; 26(1):61-3. PubMed ID: 25683360 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]